Before you sell to, join or invest in KALA BIO, Inc.
MentionFox check on KALA BIO, Inc.: no red flags found in 4 sources; 1 item to note (checked 6 November 2026). mentionfox.com/c/funding/kala-bio-inc-form-d-24000001
Check KALA BIO, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
KALA BIO, Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-31.
KALA BIO, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 31, 2024. KALA BIO, Inc. trades on Nasdaq as KALA. The filing reports $10.75M sold. Its industry group is Biotechnology. It names Mark Iwicki (Executive Officer, Director), Todd Bazemore (Executive Officer), Kim Brazzell (Executive Officer) (SEC Form D, December 31, 2024).
In its own words: “KALA BIO is a clinical-stage biopharmaceutical company focused on rare and serious eye diseases.” (kalarx.com, checked November 1, 2026)
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like KALA BIO, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-31 · the record
Pitching, partnering or investing alongside them? See who really runs and owns KALA BIO, Inc.
Free to see. No signup.
Get an email when KALA BIO, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when KALA BIO, Inc. raises, hires or launches. No email unless you switch it on.
Watch KALA BIO, Inc. →Get the full cited report on KALA BIO, Inc.
What the filing shows about KALA BIO, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on KALA BIO, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives KALA BIO, Inc.'s address as 1167 Massachusetts Avenue, Arlington, MA 02476.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for KALA BIO, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
KALA BIO, Inc. is a registered filer with the SEC (CIK 1479419) and has filed since 2024-06-28. 4 filings are on record, the latest on 2026-03-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
KALA BIO, Inc.'s Form D of 2024-12-31 names Mark Iwicki, Todd Bazemore, Kim Brazzell and 7 more as its officers, directors or promoters.
Its new offerings report $27.25M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Mark Iwicki is named as Executive Officer and Director on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Todd Bazemore is named as Executive Officer on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Kim Brazzell is named as Executive Officer on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Darius Kharabi is named as Executive Officer on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Mary Reumuth is named as Executive Officer on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Andrew Koven is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Gregory Perry is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Marjan Farid is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
Howard Rosen is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
C. Myers is named as Director on the Form D that KALA BIO, Inc. filed with the SEC on 31 December 2024, one of 10 people that filing names.
10 people named on the filing — 5 holding an executive role and 5 as directors only.
Named as of the 2024-12-31 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about KALA BIO, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on KALA BIO, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on KALA BIO, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist KALA BIO, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind KALA BIO, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for KALA BIO, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/kala-bio-inc-form-d-24000001